CEACAM5 and neoplasm: A humanized anti-CEACAM5 mAb, labetuzumab, and human monoclonal antibodies (HmAbs) were found able to suppress tumor growth and metastasis [21], [22], while other mAbs labeled with radioactive isotopes were applied for tumor imaging [23], [24].